Atlas Trials

A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants

Clinical trial NCT06454630 · COMPLETED

Trial details

NCT number
NCT06454630
Sponsor
Regeneron Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Venous Thromboembolism
Start date
2024-06-27
Primary completion
2024-11-19
Enrollment
179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.